Media and Investors Resources

Kuros Interim Results, 2023

English version

Press Release, 13 July 2023

Kuros Biosciences Announces Completion of Enrollment in the Fibrin-PTH Phase 2 Trial

Minutes of the AGM, 8 May 2023

German version

Press Release, 8 May 2023

Adhoc Press Release

Annual General Meeting of Kuros Biosciences approves all resolutions

Press Release, 27 April 2023

Adhoc Press Release

Kuros reports 168% increase in direct MagnetOs sales in the first quarter of 2023

Press Release, 15 March 2023

Adhoc Press Release

Kuros Biosciences reports results for the full year 2022